Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)

Taiwan · Delayed Price · Currency is TWD

81.20

-4.40 (-5.14%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	38.04M	44.43M	38.93M	12.82M	12.34M
Pharmaceuticals Growth	-14.40%	14.13%	203.68%	3.90%	19.22%
Total	38.04M	44.43M	38.93M	12.82M	12.34M
Total Growth	-14.40%	14.13%	203.68%	3.90%	19.22%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taiwan	38.04M	44.43M	38.93M	12.82M	12.34M
Taiwan Growth	-14.40%	14.13%	203.68%	3.90%	19.22%
Total	38.04M	44.43M	38.93M	12.82M	12.34M
Total Growth	-14.40%	14.13%	203.68%	3.90%	19.22%

Source: S&P Global Market Intelligence.